Intelligent Extracorporeal Blood Treatment Systems

Publication ID: 24-11857715_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Extracorporeal Blood Treatment Systems,” Published Technical Disclosure No. 24-11857715_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857715_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,715.

Summary of the Inventive Concept

The inventive concept integrates extracorporeal blood treatment with advanced technologies like AI, IoT, blockchain, and nanomaterials to create a more efficient, secure, and patient-centric system.

Background and Problem Solved

The original patent describes an extracorporeal blood treatment apparatus with a blood-warming device. However, this design has limitations in terms of data security, real-time monitoring, and blood-borne pathogen reduction. The new inventive concept addresses these limitations by incorporating cutting-edge technologies.

Detailed Description of the Inventive Concept

The new system comprises a blood treatment device, a blood warmer, and an extracorporeal blood circuit with a heating zone. Additionally, it integrates a blockchain-based data storage module for secure patient treatment data tracking, an AI-powered predictive analytics module for optimized priming parameters, IoT-enabled sensors for real-time monitoring, a nanomaterial-based coating for reducing blood-borne pathogens, and a machine learning-based control module for real-time adjustment of blood treatment parameters. The system also features a decentralized, IoT-enabled monitoring network for remote patient monitoring.

Novelty and Inventive Step

The new claims introduce the innovative combination of extracorporeal blood treatment with AI, IoT, blockchain, and nanomaterials, providing a synergistic solution that surpasses the capabilities of the original patent. The inventive step lies in the integration of these distinct technologies to create a more efficient, secure, and patient-centric system.

Alternative Embodiments and Variations

Alternative embodiments may include different AI algorithms for predictive analytics, various nanomaterial-based coatings for pathogen reduction, or different IoT-enabled sensor configurations. Variations may also include the use of other advanced technologies, such as augmented reality or robotics, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of blood treatment, patient monitoring, and data security. The target market includes hospitals, clinics, and research institutions, with potential for expansion into home healthcare and telemedicine.

CPC Classifications

Section	Class	Group
A	A61	A61M1/369
A	A61	A61M1/3623
A	A61	A61M1/3626
A	A61	A61M1/3627
A	A61	A61M1/3643
A	A61	A61M39/28
A	A61	A61M2205/3344
A	A61	A61M2205/36

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically extracorporeal blood treatment systems, involving complex medical instrumentation, sensor technologies, and advanced medical data management

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, proficient in medical instrumentation, sensor integration, data management technologies, and familiar with emerging technologies like AI, IoT, and blockchain in medical applications

Obviousness Rationale

A PHOSITA would recognize that integrating advanced digital technologies like AI, blockchain, and IoT into existing medical device architectures represents a predictable evolution of extracorporeal blood treatment systems. The fundamental blood treatment apparatus remains consistent with the source patent, while the added technologies provide incremental improvements in monitoring, data management, and treatment optimization. These technological additions represent well-known techniques for enhancing medical device functionality and patient care.

Obvious Combinations & Variations

Source Patent Element

Extracorporeal blood treatment apparatus with blood return line and heating zone

PTD Variation

Adding blockchain-based data storage module for patient treatment tracking

Obviousness Reasoning

Implementing secure digital record-keeping is a known technique in medical device design, representing a predictable application of blockchain technology to enhance data management and patient safety

Source Patent Element

Blood treatment device with extracorporeal blood circuit

PTD Variation

Integrating AI-powered predictive analytics module for optimizing priming parameters

Obviousness Reasoning

Using machine learning for parameter optimization is a standard approach in medical device engineering, representing a finite and predictable solution for improving treatment precision

Source Patent Element

Blood return line with heating zone

PTD Variation

Adding nanomaterial-based coating for reducing blood-borne pathogens

Obviousness Reasoning

Surface modification techniques using advanced materials are well-known in medical device design for improving biocompatibility and reducing infection risks

Source Patent Element

Extracorporeal blood treatment apparatus

PTD Variation

Implementing IoT-enabled sensors for real-time monitoring

Obviousness Reasoning

Integrating networked sensors for continuous monitoring is a standard approach in modern medical device design, representing an obvious technological enhancement

Source Patent Element

Blood treatment device with control mechanisms

PTD Variation

Adding machine learning-based control module for real-time parameter adjustment

Obviousness Reasoning

Adaptive control systems using machine learning represent a predictable technological progression for improving medical device performance and treatment precision

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857715 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed innovations obvious, as they represent predictable applications of known digital technologies to existing extracorporeal blood treatment apparatus designs. The incremental technological enhancements do not rise to the level of non-obvious innovation, and thus would be considered obvious variations by a skilled practitioner in medical device engineering.

Original Patent Information

Patent Number	US 11,857,715
Title	Extracorporeal blood treatment apparatus
Assignee(s)	Gambro Lundia AB